taxonomy (1)
protein (1)
source (3)
structure (7)
composition (23)
disease (3)
reference (7)
site (5)
peptide (12)
- Homo sapiens (Human)
Taxonomy
- Complement c3 / Homo sapiens P01024
Protein
- N-Linked / High-Mannose / Structure 2812
- N-Linked / High-Mannose / Structure 3485
- N-Linked / High-Mannose / Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Structure 3542
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 3469
Reported structure
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1875.7132 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:8 dHex:1 (avg mass : 2600.4303 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:2 (avg mass : 2664.4681 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Identification method for twelve oligomannose-type sugar chains thought to be processing intermediates of glycoproteins. (1987 - Hase S, Natsuka S, Oku H, Ikenaka T) / Status : Reviewed
Reference
- Complement c3 / Homo sapiens
Reported glycosite
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREFK (24aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREF (23aa)
- NHMGNVTFTIPANR (14aa)
- TNHMGNVTFTIPANR (15aa)
- MGNVTFTIPANR (12aa)
- TVLTPATNHMGNVTF (15aa)
- HMGNVTFTIPANR (13aa)
- VVPEGIRMNK (10aa)
- GIRMNKTVAVRTLDPE (16aa)
- HYLMWGLSSDFWGEKPNLSYIIGK (24aa)
Mass spectrometry observed peptide
-
- N-Linked / High-Mannose (avg mass : 1235.1173)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Complement c3 / Homo sapiens
- Complement c3 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1397.2597)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Complement c3 / Homo sapiens
- Complement c3 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
- Blood Serum (UBERON_0001977)
-
Complement c3 / Homo sapiens
- Undefined site
- Complement c3 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
- Blood Serum (UBERON_0001977)
-
Complement c3 / Homo sapiens
- Undefined site
- Complement c3 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Complement c3 / Homo sapiens
- Complement c3 / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1721.5445)
- Blood Serum (UBERON_0001977)
-
Complement c3 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid (avg mass : 1891.7126)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Complement c3 / Homo sapiens
- Complement c3 / Homo sapiens
-
- Hex:4 HexNAc:2 / N-Linked (avg mass : 1072.9749)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
-
- Hex:3 HexNAc:3 / N-Linked (avg mass : 1114.0275)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- N-Linked / High-Mannose / Structure 2812
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREFK (24aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREF (23aa)
- TNHMGNVTFTIPANR (15aa)
- TVLTPATNHMGNVTF (15aa)
- HMGNVTFTIPANR (13aa)
-
- Hex:4 HexNAc:3 / N-Linked (avg mass : 1276.1699)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TNHMGNVTFTIPANR (15aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREFK (24aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREF (23aa)
- NHMGNVTFTIPANR (14aa)
- MGNVTFTIPANR (12aa)
- TNHMGNVTFTIPANR (15aa)
- TVLTPATNHMGNVTF (15aa)
- HMGNVTFTIPANR (13aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- N-Linked / High-Mannose / Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Structure 3542
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANREFK (24aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TNHMGNVTFTIPANR (15aa)
- TVLTPATNHMGNVTF (15aa)
- HMGNVTFTIPANR (13aa)
-
- Hex:3 HexNAc:6 / N-Linked (avg mass : 1723.6125)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- TVITPATNHMGNVTFTIPANR (21aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TNHMGNVTFTIPANR (15aa)
-
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1875.7132)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- TNHMGNVTFTIPANR (15aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- TVITPATNHMGNVTFTIPANR (21aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVITPATNHMGNVTFTIPANR (21aa)
- TNHMGNVTFTIPANR (15aa)
- HMGNVTFTIPANR (13aa)
-
- Hex:3 HexNAc:7 / N-Linked (avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
- GIRMNKTVAVRTLDPE (16aa)
-
- Hex:6 HexNAc:6 dHex:1 / N-Linked (avg mass : 2356.1827)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:5 HexNAc:8 dHex:1 / N-Linked (avg mass : 2600.4303)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:7 HexNAc:6 dHex:2 / N-Linked (avg mass : 2664.4681)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked (avg mass : 2736.5316)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Complement c3 / Homo sapiens
- TVLTPATNHMGNVTFTIPANR (21aa)
- TVLTPATNHMGNVTFTIPANR (21aa)
-
- Hex:8 HexNAc:7 dHex:1 / N-Linked (avg mass : 2883.6625)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement c3 / Homo sapiens
- VVPEGIRMNK (10aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked (avg mass : 3683.3567)
- Blood Serum (UBERON_0001977)
- Complement c3 / Homo sapiens
- HYLMWGLSSDFWGEKPNLSYIIGK (24aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
